Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Italian Journal of Pediatrics
Published in: Italian Journal of Pediatrics 1/2023

Open Access 01-12-2023 | Respiratory Syncytial Virus Infection | Review

Bronchiolitis guidelines: what about the Italian situation in a primary care setting?

Authors: Federica Porcaro, Renato Cutrera, Anna Chiara Vittucci, Alberto Villani

Published in: Italian Journal of Pediatrics | Issue 1/2023

Login to get access

Abstract

Acute viral bronchiolitis is the most common cause of hospitalization in children under 12 months of age. The variable clinical presentation and the potential for sudden deterioration of the clinical conditions require a close monitoring by healthcare professionals.
In Italy, first access care for children is provided by primary care physicians (PCPs) who often must face to a heterogeneous disease presentation that, in some cases, make the management of patient with bronchiolitis challenging. Consequently, Italian studies report poor adherence to national and international guidelines processed to guide the clinicians in decision making in acute viral bronchiolitis.
This paper aims to identify the potential factors contributing to the lack of adherence to the suggested guidelines derived by clear and evidence-based recommendations among primary care physicians operating in an outpatient setting, with a specific focus on the context of Italy. Particularly, we focus on the prescription of medications such as β2-agonists, systemic steroids, and antibiotics which are commonly prescribed by PCPs to address conditions that can mimic bronchiolitis.
Appendix
Available only for authorised users
Literature
1.
Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. Lancet Lond Engl. 2017;389:211–24.CrossRef
2.
Baraldi E, Lanari M, Manzoni P, Rossi GA, Vandini S, Rimini A, et al. Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants. Ital J Pediatr. 2014;40:65.CrossRefPubMedPubMedCentral
3.
Verstraete M, Cros P, Gouin M, Oillic H, Bihouée T, Denoual H, et al. [Update on the management of acute viral bronchiolitis: proposed guidelines of Grand Ouest University Hospitals]. Arch Pediatr Organe off Soc Francaise Pediatr. 2014;21:53–62.
4.
5.
Manti S, Staiano A, Orfeo L, Midulla F, Marseglia GL, Ghizzi C, et al. UPDATE – 2022 italian guidelines on the management of bronchiolitis in infants. Ital J Pediatr. 2023;49:19.CrossRefPubMedPubMedCentral
6.
O’Brien S, Borland ML, Cotterell E, Armstrong D, Babl F, Bauert P, et al. Australasian bronchiolitis guideline. J Paediatr Child Health. 2019;55:42–53.CrossRefPubMed
7.
Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014;134:e1474–1502.CrossRefPubMed
8.
Friedman JN, Rieder MJ, Walton JM, Canadian Paediatric Society, Acute Care Committee. Drug Therapy and Hazardous Substances Committee. Bronchiolitis: recommendations for diagnosis, monitoring and management of children one to 24 months of age. Paediatr Child Health. 2014;19:485–98.CrossRefPubMedPubMedCentral
9.
Nebot MS, Teruel GC, Cubells CL, Sabadell MDE, Fernández JP. [Acute bronchiolitis clinical practice guideline: recommendations for clinical practice]. An Pediatr Barc Spain. 2003;2010:73–208e1.
10.
Green RJ, Zar HJ, Jeena PM, Madhi SA, Lewis H. South african guideline for the diagnosis, management and prevention of acute viral bronchiolitis in children. South Afr Med J Suid-Afr Tydskr Vir Geneeskd. 2010;100(320):322–5.
11.
Jartti T, Smits HH, Bønnelykke K, Bircan O, Elenius V, Konradsen JR, et al. Bronchiolitis needs a revisit: distinguishing between virus entities and their treatments. Allergy. 2019;74:40–52.CrossRefPubMed
12.
Dalziel SR, Haskell L, O’Brien S, Borland ML, Plint AC, Babl FE, et al. Bronchiolitis Lancet Lond Engl. 2022;400:392–406.CrossRef
13.
Vittucci AC, Spuri Vennarucci V, Grandin A, Russo C, Lancella L, Tozzi AE, et al. Pertussis in infants: an underestimated disease. BMC Infect Dis. 2016;16:414.CrossRefPubMedPubMedCentral
14.
Flores G, Horwitz RI. Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics. 1997;100:233–9.CrossRefPubMed
15.
16.
Hartling L, Fernandes RM, Bialy L, Milne A, Johnson D, Plint A, et al. Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis. BMJ. 2011;342:d1714.CrossRefPubMedPubMedCentral
17.
Schuh S, Coates AL, Binnie R, Allin T, Goia C, Corey M, et al. Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. J Pediatr. 2002;140:27–32.CrossRefPubMed
18.
Bentur L, Shoseyov D, Feigenbaum D, Gorichovsky Y, Bibi H. Dexamethasone inhalations in RSV bronchiolitis: a double-blind, placebo-controlled study. Acta Paediatr Oslo nor 1992. 2005;94:866–71.
19.
Kuyucu S, Unal S, Kuyucu N, Yilgor E. Additive effects of dexamethasone in nebulized salbutamol or L-epinephrine treated infants with acute bronchiolitis. Pediatr Int off J Jpn Pediatr Soc. 2004;46:539–44.
20.
Mesquita M, Castro-Rodríguez JA, Heinichen L, Fariña E, Iramain R. Single oral dose of dexamethasone in outpatients with bronchiolitis: a placebo controlled trial. Allergol Immunopathol (Madr). 2009;37:63–7.CrossRefPubMed
21.
Alansari K, Sakran M, Davidson BL, Ibrahim K, Alrefai M, Zakaria I. Oral dexamethasone for bronchiolitis: a randomized trial. Pediatrics. 2013;132:e810–816.CrossRefPubMed
22.
Farley R, Spurling GKP, Eriksson L, Del Mar CB. Antibiotics for bronchiolitis in children under two years of age. Cochrane Database Syst Rev. 2014;CD005189.
23.
Kirolos A, Manti S, Blacow R, Tse G, Wilson T, Lister M, et al. A systematic review of clinical practice guidelines for the diagnosis and management of Bronchiolitis. J Infect Dis. 2020;222:672–9.CrossRef
24.
25.
Cutrera R, Baraldi E, Indinnimeo L, Miraglia Del Giudice M, Piacentini G, Scaglione F, et al. Management of acute respiratory diseases in the pediatric population: the role of oral corticosteroids. Ital J Pediatr. 2017;43:31.CrossRefPubMedPubMedCentral
26.
Rossi GA, Colin AA. Infantile respiratory syncytial virus and human rhinovirus infections: respective role in inception and persistence of wheezing. Eur Respir J. 2015;45:774–89.CrossRefPubMed
27.
Al-Shawwa B, Al-Huniti N, Weinberger M, Abu-Hasan M. Clinical and therapeutic variables influencing hospitalisation for bronchiolitis in a community-based paediatric group practice. Prim Care Respir J J Gen Pract Airw Group. 2007;16:93–7.CrossRef
28.
Rivera-Sepulveda AV, Rebmann T, Gerard J, Charney RL. Physician compliance with Bronchiolitis Guidelines in Pediatric Emergency Departments. Clin Pediatr (Phila). 2019;58:1008–18.CrossRefPubMed
29.
Barr R, Carande EJ, Pollard AJ, Drysdale SB. Change in viral bronchiolitis management in hospitals in the UK after the publication of NICE guideline. J Clin Virol off Publ Pan Am Soc Clin Virol. 2018;105:84–7.CrossRef
30.
Manti S, Licari A, Brambilla I, Caffarelli C, Calvani M, Cardinale F, et al. Agreements and controversies of national guidelines for bronchiolitis: results from an italian survey. Immun Inflamm Dis. 2021;9:1229–36.CrossRefPubMedPubMedCentral
31.
Barbieri E, Cantarutti A, Cavagnis S, Cantarutti L, Baraldi E, Giaquinto C, et al. Impact of bronchiolitis guidelines publication on primary care prescriptions in the italian pediatric population. NPJ Prim Care Respir Med. 2021;31:15.CrossRefPubMedPubMedCentral
32.
Biagi C, Scarpini S, Paleari C, Fabi M, Dondi A, Gabrielli L, et al. Impact of Guidelines publication on Acute Bronchiolitis Management: 10-Year experience from a Tertiary Care Center in Italy. Microorganisms. 2021;9:2221.CrossRefPubMedPubMedCentral
33.
Carlone G, Graziano G, Trotta D, Cafagno C, Aricò MO, Campodipietro G et al. Bronchiolitis 2021–2022 epidemic: multicentric analysis of the characteristics and treatment approach in 214 children from different areas in Italy. Eur J Pediatr [Internet]. 2023 [cited 2023 Apr 3]; https://​doi.​org/​10.​1007/​s00431-023-04853-0.
34.
Gadomski AM, Lichenstein R, Horton L, King J, Keane V, Permutt T. Efficacy of albuterol in the management of bronchiolitis. Pediatrics. 1994;93:907–12.CrossRefPubMed
35.
Gadomski AM, Aref GH, el Din OB, el Sawy IH, Khallaf N, Black RE. Oral versus nebulized albuterol in the management of bronchiolitis in Egypt. J Pediatr. 1994;124:131–8.CrossRefPubMed
36.
Gupta P, Aggarwal A, Gupta P, Sharma KK. Oral salbutamol for symptomatic relief in mild bronchiolitis a double blind randomized placebo controlled trial. Indian Pediatr. 2008;45:547–53.PubMed
37.
Alario AJ, Lewander WJ, Dennehy P, Seifer R, Mansell AL. The efficacy of nebulized metaproterenol in wheezing infants and young children. Am J Dis Child 1960. 1992;146:412–8.
38.
Goebel J, Estrada B, Quinonez J, Nagji N, Sanford D, Boerth RC. Prednisolone plus albuterol versus albuterol alone in mild to moderate bronchiolitis. Clin Pediatr (Phila). 2000;39:213–20.CrossRefPubMed
39.
Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2013;2013:CD004878.PubMedPubMedCentral
40.
Schuh S, Canny G, Reisman JJ, Kerem E, Bentur L, Petric M, et al. Nebulized albuterol in acute bronchiolitis. J Pediatr. 1990;117:633–7.CrossRefPubMed
41.
Gelbart B, McSharry B, Delzoppo C, Erickson S, Lee K, Butt W, et al. Pragmatic randomized trial of Corticosteroids and Inhaled Epinephrine for Bronchiolitis in Children in Intensive Care. J Pediatr. 2022;244:17–23e1.CrossRefPubMed
42.
Rodriguez-Martinez CE, Sossa-Briceño MP, Nino G. Systematic review of instruments aimed at evaluating the severity of bronchiolitis. Paediatr Respir Rev. 2018;25:43–57.PubMed
43.
Abbate F, Depietri G, Tinelli C, Massimetti G, Picariello S, Peroni D et al. Impact of the publication of the Italian guidelines for bronchiolitis on the management of hospitalized children in Pisa, Italy. Pediatr Pulmonol. 2023.
44.
Wall MA. Bronchodilators and steroids should not be given in viral bronchiolitis - CON. Paediatr Respir Rev. 2019;32:20–2.PubMed
Metadata
Title
Bronchiolitis guidelines: what about the Italian situation in a primary care setting?
Authors
Federica Porcaro
Renato Cutrera
Anna Chiara Vittucci
Alberto Villani
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Italian Journal of Pediatrics / Issue 1/2023
Electronic ISSN: 1824-7288
DOI
https://doi.org/10.1186/s13052-023-01527-3

Other articles of this Issue 1/2023

Italian Journal of Pediatrics 1/2023 Go to the issue

Debate

Novel insect-based child nutrition: the position of the nutritional committee of the Italian society of pediatric gastroenterology, hepatology and nutrition (SIGENP)

Research

Concordance of adenosine deaminase with immunoglobulins and lymphocyte subsets in EBV-related diseases

Review

The treatment of obesity in children and adolescents: consensus position statement of the Italian society of pediatric endocrinology and diabetology, Italian Society of Pediatrics and Italian Society of Pediatric Surgery

Research

Evaluation of thiol disulfide balance in adolescents with vitamin B12 deficiency

Research

Primary care pediatricians and job satisfaction: a cross sectional study in the Lazio region

Review

Management of pulmonary aspergillosis in children: a systematic review